CPT Code: 80061; (and 83721 if Direct LDL performed)
Lipid Panel: C906 (includes Total Cholesterol, Triglyceride, Direct HDL, Calculated LDL and Non-HDL Cholesterol)
Lipid Panel and Direct LDL Cholesterol: C909 (includes Total Cholesterol, Triglyceride, Direct HDL, Non-HDL Cholesterol and Direct LDL if Triglyceride is greater than 400 mg/dL.)
Refer to individual tests for assay information.
ABN Requirement: No
Volume: 2.0 mL
Minimum Volume: 1.0 mL
Container: Gel-barrier tube (SST, Tiger Top)
- Collect and label sample according to standard protocols.
- Gently invert tube 5 times immediately after draw. DO NOT SHAKE.
- Allow blood to clot 30 minutes.
- Centrifuge at 1300 rcf for 10 minutes.
Patient Preparation: Fasting is preferred
Transport: Store serum at 2° to 8°C after collection and ship the same day per packaging instructions provided with the Cleveland HeartLab, Inc. shipping box.
Ambient (15-25°C): not acceptable
Refrigerated (2-8°C): 7 days
Frozen (-20°C): 14 days
Deep Frozen (-70°): 30 days
Causes of Rejection: Specimens other than serum; improper labeling; samples not stored properly; samples older than stability limits.
Turn Around Time: 1 to 3 days
|HDL, Direct||0-19 years||>45||N/A||<50|
|≥20 years, Female||>49||N/A||<50|
|≥20 years, Male||>39||N/A||<40|
|LDL, Calculated||0-19 years||<110||110-129||>129|
|Non-HDL Cholesterol||0-19 years||<120||120-144||>144|
|LDL, Direct||0-19 years||<110||110-129||>129|
Use: The lipid panel is used, along with other tests, during routine assessment to determine an individual’s risk of cardiovascular disease. A lipid panel can also be used to monitor the efficacy of lifestyle interventions or medications.
Limitations: Intralipid causes artificially high LDL cholesterol results. In some patients with abnormal liver function, the LDL-cholesterol result is significantly negatively biased versus beta quantification results. In very rare cases gammopathy may cause unreliable results.
Additional Information: Adults without other risk factors for heart disease should receive a lipid panel once every five years. Individuals who have had an abnormal lipid panel, or those who have other cardiovascular risk factors, may be tested more frequently.